MAD Phase I Study to Investigate Contraloid Acetate

Conditions:   Alzheimer Dementia;   Alzheimer Disease Intervention:   Drug: Contraloid Sponsors:   Prof. Dr. Dieter Willbold;   Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany;   Medical University of Vienna;   NeuroScios, Austria;   Nuvisan, Germany;   Fundación Teófilo Hernando, Spain;   Alzheimer's Association Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials